Reducing Risk of Diabetic Ketoacidosis in Type 1 Diabetes and Kidney Disease Using Continuous Ketone Monitoring

NCT07325201 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes Mellitus
Chronic Kidney Disease (CKD) With Diabetes Mellitus (DM)
Chronic Kidney Disease

Interventions

DRUG: Sotagliflozin initiation

Sponsor

HealthPartners Institute

Collaborators

[object Object]